Associated Papers
[Mutation pedigree and treatment selection of Erdheim-Chester disease].
Lang M et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, 2023
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Durham BH et al.
Nature Medicine, 2019
31768065 (PubMed )
Supplement: NIHMS1541330-supplement-1.pdf
The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort.
Ozkaya N et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2018
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.
Diamond EL et al.
Cancer Discovery, 2016
Select a paper to view details